Towards the Future: Synergizing Efforts for the Next Generation of Cell Therapeutics

The use of cells to cure disease is rapidly gaining momentum. Nevertheless, the development of cell-based therapies has been impacted by the complexity of the product, i.e. both biological and logistical/manufacturing challenges, and the cost.

Due to this complex nature of cell therapy products, partnering for their successful commercial development seems inevitable to overcome these developmental challenges.

In this symposium, we aim to drive the translation of cell therapy from the bench to the bedside by facilitating increased levels of interaction between the various partners of the developmental value chain.






14:00 - 15:30

Plenary session

14:00 - 14:30

Lessons learned from the first generation of cell therapeutics. Where do we go from here?

Wilfried Dalemans, CTO, Tigenix

14:30 - 15:00

Tailor-made regulatory support by the National Innovation Office

Christophe Lahorte, Federal Agency for Medicines and Health Products

15:00 - 15:30

Cell therapeutics for unresolved conditions: the case of perianal Crohn’s disease

Gert Van Assche, UZLeuven

15:30 - 16:00

Coffee Break

16:00 - 17:30

Pitchers cell therapy value chain

16:00 - 16:10

Introduction of the RegMed platform

Jan Schrooten, Antleron

16:10 - 16:20

Advancing innovative cell therapy solutions to the patient

Nathalie Cools, University of Antwerp, copromotor, Anicells

16:20 - 16:30

Insights into the importance and difficulties of quality/compliance in the field of personalised medicine (for current and future processes)

Bart Van Acker, Managing Director, QbD

16:30 - 16:40

Safety First: A quality control pipeline in your cell therapy development journey

Griet Nuytinck, CEO, Group Nuytinck

16:40 - 16:50, from cell culture quality control to actionable insights for efficient cell production

Toon Lambrechts, KULeuven

16:50 - 17:00

Towards personalised manufacturing 4.0

Jan Schrooten, Managing director, Antleron

17:00 - 17:10

Cell therapy: standardized intradermal injection to the rescue

Vanessa Vankerckhoven, CEO, Novosanis

17:10 - 17:20

Precious cargo: Right Away delivery of cell therapeutics

Peter Allard, Managing director, RightAway

17:20 - 17:30

Closing remarks

Henk Joos, Managing Director,

17:30 - 19:00

Networking event

Event Details


Tuesday, June 13, 2017 (13:00 h - 19:00 h)


Incubator Darwin, Galileilaan 15, 2845 NIEL


Free of charge but registration is mandatory



2017-06-13 13:00:00 2017-06-13 19:00:00 Europe/Brussels Towards the Future: Synergizing Efforts for the Next Generation of Cell Therapeutics Incubator Darwin, Galileilaan 15, 2845 NIEL

More info?

For any further information about this event, please do not hesitate to get in touch with our Communications Coordinator

Alternate Text

Jonas De Backer

Communications Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?